ORGANIZATIONAL CHANGES - POLICY |
|
Policy and Procedures Regarding Organizational Changes |
1005.1 |
Guidelines for FDA Organizational Name Charts |
1005.2 |
ADMINISTRATIVE (ORGANIZATIONAL) CODES |
|
Control and Use of Standard Administrative Codes |
1010.1 |
OFFICE OF THE COMMISSIONER |
|
Food and Drug Administration Mission |
1110.1 |
Office of the Commissioner |
1111.1 |
Office of the Chief Counsel |
1111.2a |
Office of the Executive Secretariat |
1111.3a |
Office of Counselor to the Commissioner |
1111.4a |
Office of Digital Transformation |
1111.5A |
Office of Information Management and Technology |
1111.51a |
Office of Technology and Delivery |
1111.511 |
Division of Infrastructure Operations |
1111.5111 |
Division of Application Services |
1111.5112 |
Office of Business and Customer Assurance |
1111.512 |
Division of Business Partnership and Support |
1111.5121 |
Division of Management Services |
1111.5122 |
Office of Enterprise Portfolio Management |
1111.513 |
Office of Information Security |
1111.52a |
Office of Data, Analytics, and Research |
1111.53a |
Oncology Center of Excellence |
1112A.1 |
Office of Clinical Policy and Programs |
1113B.1 |
Office of Clinical Policy |
1113B.2 |
Office of Combination Products |
1113B.3 |
Office of Orphan Products Development |
1113B.4 |
Office of Pediatric Therapeutics |
1113B.5 |
Office of External Affairs |
1114A.1 |
Office of Editorial and Creative Services |
1114A.2 |
Office of Media Affairs |
1114A.3 |
Office of Food Policy and Response |
1115A.1 |
Office of Priority Policy Initiatives |
1115A.2 |
Office of Resource Planning and Strategic Management |
1115A.3 |
Office of Minority Health and Health Equity |
1116A.1 |
Office of Policy, Legislation, and International Affairs |
1118A.1 |
Office of Congressional Appropriations |
1118A.2 |
Office of Economics and Analysis |
1118A.3 |
Office of Global Policy and Strategy |
1118A.4 |
Office of Communications, Evaluation and Logistics |
1118A.41 |
Office of Global Operations |
1118A.42 |
Office of Trade and Global Partnerships |
1118A.43 |
Office of Legislation |
1118A.5 |
Office of Policy |
1118A.6 |
Office of the Chief Scientist |
1119A.1 |
Office of Counter-Terrorism and Emerging Threats |
1119A.2 |
Office of Laboratory Safety |
1119A.3 |
Office of Regulatory Science and Innovation |
1119A.4 |
Office of Scientific Integrity |
1119A.5 |
Office of Scientific Professional Development |
1119A.6 |
National Center for Toxicological Research |
1280.1 |
Office of the Center Director, NCTR |
1281.1 |
Office of Research |
1283.1 |
Division of Genetic and Molecular Toxicology |
1283.2 |
Division of Biochemical Toxicology |
1283.4 |
Division of Systems Biology |
1283.7 |
Division of Microbiology |
1283.8 |
Division of Neurotoxicology |
1283.9 |
Division of Bioinformatics and Biostatistics |
1283.12 |
Office of Management |
1284.1 |
Office of Scientific Coordination |
1285.1 |
Office of Women's Health |
1130A.1 |
Office of Operations |
1117A.1 |
Office of Enterprise Management Services |
1117A.2 |
Division of Compliance and Conflict Prevention |
1117A.21 |
Division of Human Capital |
1117A.22 |
Division of Information Governance |
1117A.23 |
Division of Resources Management |
1117A.24 |
Division of Vendor Management |
1117A.25 |
Office of Ethics and Integrity |
1117A.3 |
Office of Equal Employment Opportunity |
1117A.4 |
Office of Finance, Budget, Acquisitions, and Planning |
1117A.6 |
Office of Budget |
1117A.61 |
Division of Budget Formulation |
1117A.611 |
Division of Budget Execution and Control |
1117A.612 |
Office of Acquisitions and Grants Services |
1117A.62 |
Division of Acquisition Operations |
1117A.621 |
Division of Acquisition Programs |
1117A.622 |
Division of Grants, Agreements, and Acquisition Support |
1117A.623 |
Division of Information Technology Acquisitions |
1117A.624 |
Division of Policy, Systems and Program Support |
1117A.625 |
Office of Financial Management |
1117A.63 |
Division of Accounting |
1117A.631 |
Division of Payment Services |
1117A.633 |
Division of Travel Services |
1117A.634 |
Office of Planning, Evaluation, and Risk Management |
1117A.64 |
Division of Performance Management |
1117A.641 |
Division of Evaluation and Analytics |
1117A.642 |
Division of Controls, Compliance, and Oversight |
1117A.643 |
Division of Planning, Program Alignment, and Management |
1117A.644 |
Division of Enterprise Risk Management |
1117A.645 |
Office of Facilities Engineering and Mission Support Services |
1117A.8 |
Division of Operations Management and Community Relations |
1117A.81 |
Division of Planning, Engineering and Space Management |
1117A.82 |
Office of Security and Emergency Management |
1117A.9 |
Office of Security Operations |
1117A.91 |
Office of Emergency Management |
1117A.92 |
Office of Emergency Operations |
1117A.921 |
Office of Human Capital Management |
1117A.10 |
Division of FDA Training and Development |
1117A.101 |
Division of Human Resources Systems and Operations Support |
1117A.102 |
Division of Employee and Labor Relations |
1117A.103 |
Division of Strategic Talent Management Programs |
1117A.104 |
Office of Talent Solutions |
1117A.11 |
Division of Talent Services I |
1117A.111 |
Division of Talent Services II |
1117A.112 |
Division of Talent Services III |
1117A.113 |
Division of Talent Services IV |
1117A.114 |
Division of Talent Sourcing and Staffing |
1117A.115 |
|
|
Center for Food Safety and Applied Nutrition |
1230A.1 |
Office of the Center Director |
1231.10 |
Office of Management |
1231.11 |
Division of Budget and Planning |
1231.110 |
Division of Workforce Management |
1231.111 |
Division of Information Technology Management |
1231.112 |
Office of Analytics and Outreach |
1231.12 |
Division of Education, Outreach and Information |
1231.121 |
Division of Public Health Informatics and Analytics |
1231.122 |
Division of Risk and Decision Analysis |
1231.123 |
Office of Food Safety |
1231.13 |
Division of Seafood Science and Technology |
1231.131 |
Division of Food Processing Science and Technology |
1231.132 |
Division of Seafood Safety |
1231.134 |
Division of Produce Safety |
1231.135 |
Division of Dairy, Egg, and Meat Products |
1231.136 |
Division of Plant Products and Beverages |
1231.137 |
Office of Cosmetics and Colors |
1231.14 |
Division of Color Certification and Technology |
1231.141 |
Division of Cosmetics |
1231.142 |
Office of Regulatory Science |
1231.15 |
Division of Analytical Chemistry |
1231.151 |
Division of Microbiology |
1231.152 |
Division of Bioanalytical Chemistry |
1231.153 |
Office of Food Additive Safety |
1231.16 |
Division of Food Contact Substances |
1231.161 |
Division of Food Ingredients |
1231.162 |
Division of Science and Technology |
1231.163 |
Office of Compliance |
1231.17 |
Division of Enforcement |
1231.171 |
Division of Field Programs and Guidance |
1231.172 |
Office of Applied Research and Safety Assessment |
1231.18 |
Division of Molecular Biology |
1231.181 |
Division of Virulence Assessment |
1231.182 |
Division of Toxicology |
1231.183 |
Office of Regulations and Policy |
1231.19 |
Office of Nutrition and Food Labeling |
1231.20 |
Division of Food Labeling and Standards |
1231.200 |
Division of Nutrition Programs |
1231.201 |
Office of Dietary Supplement Programs |
1231.21 |
Division of Research and Evaluation |
1231.210 |
Division of Policy and Regulations Implementation |
1231.211 |
Office of Executive Programs |
1231.22 |
Office of Coordinated Outbreak Response and Evaluation Network |
1231.23 |
Office of International Engagement |
1231.24 |
Center for Veterinary Medicine |
1240.1 |
Office of the Center Director |
1241.1 |
Office of Management |
1242.1 |
Office of New Animal Drug Evaluation |
1243.1 |
Division of Food Animal Drugs |
1243.10 |
Division of Therapeutic Drugs for Food Animals |
1243.10a |
Division of Production Drugs |
1243.11 |
Division of Companion Animal Drugs |
1243.12 |
Division of Therapeutic Drugs for Non-Food Animals |
1243.12a |
Division of Human Food Safety |
1243.13 |
Division of Manufacturing Technologies |
1243.14 |
Division of Scientific Support |
1243.15 |
Division of Generic Animal Drugs |
1243.16 |
Division of Business Information Science and Management |
1243.17 |
Division of Animal Bioengineering and Cellular Therapies |
1243.18 |
Office of Surveillance and Compliance |
1244.1 |
Division of Pharmacovigilance and Surveillance |
1244.10 |
Division of Animal Food Ingredients |
1244.11 |
Division of Drug Compliance |
1244.12 |
Division of Food Compliance |
1244.14 |
Office of Applied Science |
1245.1 |
Division of Residue Chemistry |
1245.10 |
Division of Applied Veterinary Research |
1245.11 |
Division of One Health Monitoring |
1245.12 |
Division of Emerging Technologies |
1245.13 |
Office of Minor Use and Minor Species Animal Drug Development |
1246.1 |
Center for Biologics Evaluation and Research |
1210.1 |
Office of the Center Director |
1211.1 |
Office of Management |
1211.10 |
Division of Program Services |
1211.13 |
Division of Scientific Advisors and Consultants |
1211.14a |
Division of Veterinary Services |
1211.15a |
Division of Human Capital |
1211.16 |
Division of Acquisitions and Budget Resources |
1211.17 |
Division of Management Planning and Analysis |
1211.18 |
Office of Compliance and Biologics Quality |
1212.1 |
Division of Case Management |
1212.2 |
Division of Inspections and Surveillance |
1212.4 |
Division of Manufacturing and Product Quality |
1212.5 |
Division of Biological Standards and Quality Control |
1212.6 |
Office of Biostatistics and Pharmacovigilance |
1213.1 |
Division of Biostatistics |
1213.2 |
Division of Pharmacovigilance |
1213.3 |
Division of Analytics and Benefit-Risk Assessment |
1213.4 |
Office of Blood Research and Review |
1215.1 |
Division of Emerging and Transfusion Transmitted Diseases |
1215.2 |
Division of Blood Components and Devices |
1215.6 |
Office of Vaccines Research and Review |
1217.1 |
Division of Bacterial, Parasitic and Allergenic Products |
1217.2 |
Division of Viral Products |
1217.4 |
Division of Review Management and Regulatory Review |
1217.6 |
Division of Clinical and Toxicology Review |
1217.7 |
Office of Therapeutic Products |
1218A.1 |
Office of Gene Therapy |
1218A.2 |
Division of Gene Therapy I |
1218A.21 |
Division of Gene Therapy II |
1218A.22 |
Office of Cellular Therapy and Human Tissue CMC |
1218A.3 |
Division of Cell Therapy I |
1218A.31 |
Division of Cell Therapy II |
1218A.32 |
Division of Human Tissues |
1218A.33 |
Office of Plasma Protein Therapeutics CMC |
1218A.4 |
Division of Hemostasis |
1218A.41 |
Division of Plasma Derivatives |
1218A.42 |
Office of Clinical Evaluation |
1218A.5 |
Division of Clinical Evaluation General Medicine |
1218A.51 |
Division of Clinical Evaluation Oncology |
1218A.52 |
Division of Clinical Evaluation Hematology |
1218A.53 |
Office of Pharmacology/Toxicology |
1218A.6 |
Division of Pharmacology/Toxicology I |
1218A.61 |
Division of Pharmacology/Toxicology II |
1218A.62 |
Office of Review Management and Regulatory Review |
1218A.7 |
Division of Review Management and Regulatory Review I |
1218A.71 |
Division of Review Management and Regulatory Review II |
1218A.72 |
Office of Communication, Outreach and Development |
1219.1 |
Division of Disclosure and Oversight Management |
1219.2 |
Division of Manufacturers Assistance and Training |
1219.3 |
Division of Communication and Consumer Affairs |
1219.4 |
Office of Regulatory Operations |
1220.1 |
Division of Informatics |
1220.2 |
Division of Regulatory Operations and Programs |
1220.3 |
Division of Information Technology |
1220.4 |
Center for Devices and Radiological Health |
1250.1 |
Office of the Center Director |
1251.1 |
Office of Management |
1251.10 |
Division of Workforce Management |
1251.12 |
Division of Financial Management |
1251.13 |
Division of Management Services |
1251.14a |
Division of Acquisition Services |
1251.15a |
Office of Strategic Partnerships and Technology Innovation |
1251A.20 |
Division of All Hazards Response, Science and Strategic Partnerships |
1251.21a |
Division of Digital Health |
1251.22a |
Division of Technology and Data Services |
1251.23a |
Office of Policy |
1251.30 |
Office of Science and Engineering Laboratories |
1254.1 |
Division of Administrative and Laboratory Support |
1254.2a |
Division of Biology, Chemistry, and Materials Science |
1254.3a |
Division of Applied Mechanics |
1254.5 |
Division of Biomedical Physics |
1254.9 |
Division of Imaging, Diagnostics, and Software Reliability |
1254.10 |
Office of Communication and Education |
1255.1 |
Division of Industry and Consumer Education |
1255.4 |
Division of Communication |
1255.9 |
Division of Information Disclosure |
1255.10 |
Division of Employee Training and Development |
1255.11 |
Office of Product Evaluation and Quality |
1258.1 |
Office of Regulatory Programs |
1258.10 |
Division of Regulatory Programs I |
1258.11 |
Division of Regulatory Programs II |
1258.12 |
Division of Regulatory Programs III |
1258.13 |
Division of Regulatory Programs IV |
1258.14 |
Office of Clinical Evidence and Analysis |
1258.20 |
Division of Clinical Evidence and Analysis I |
1258.21 |
Division of Clinical Evidence and Analysis II |
1258.22 |
Division of Clinical Evidence and Analysis III |
1258.23 |
Office of Health Technology I |
1258.30 |
Division of Health Technology I A |
1258.31 |
Division of Health Technology I B |
1258.32 |
Division of Health Technology I C |
1258.33 |
Office of Health Technology II |
1258.40 |
Division of Health Technology II A |
1258.41 |
Division of Health Technology II B |
1258.42 |
Division of Health Technology II C |
1258.43 |
Office of Health Technology III |
1258.50 |
Division of Health Technology III A |
1258.51 |
Division of Health Technology III B |
1258.52 |
Division of Health Technology III C |
1258.53 |
Office of Health Technology IV |
1258.60 |
Division of Health Technology IV A |
1258.61 |
Division of Health Technology IV B |
1258.62 |
Office of Health Technology V |
1258.70 |
Division of Health Technology V A |
1258.71 |
Division of Health Technology V B |
1258.72 |
Office of Health Technology VI |
1258.80 |
Division of Health Technology VI A |
1258.81 |
Division of Health Technology VI B |
1258.82 |
Division of Health Technology VI C |
1258.83 |
Office of Health Technology VII |
1258.90 |
Division of Chemistry, and Toxicology Devices |
1258.91 |
Division of Immunology and Hematology Devices |
1258.92 |
Division of Microbiology Devices |
1258.93 |
Division of Program Operations and Management |
1258.95 |
Division of Molecular Genetics and Pathology |
1258.97 |
Office of Health Technology VIII |
1258.100 |
Division of Health Technology VIII A |
1258.101 |
Division of Health Technology VIII B |
1258.102 |
Division of Health Technology VIII C |
1258.103 |
Center for Drug Evaluation and Research |
1260.1 |
Office of the Center Director |
1261.1 |
Office of Regulatory Policy |
1260.2 |
Division of Regulatory Policy I |
1260.21 |
Division of Regulatory Policy II |
1260.22 |
Division of Information Disclosure Policy |
1260.23 |
Division of Regulatory Policy III |
1260.24 |
Division of Regulatory Policy IV |
1260.25 |
Office of Management |
1261.10 |
Division of Budget Execution and Resource Management |
1261.11 |
Division of Management Services |
1261.17 |
Division of User Fee Management and Budget Formulation |
1261.18 |
Office of Communications |
1261.20 |
Division of Digital and Online Communications |
1261.22 |
Division of Health Communication |
1261.25 |
Division of Drug Information |
1261.26 |
Office of Surveillance and Epidemiology |
1261.5 |
Office of Medication Error Prevention and Risk Management |
1261.57 |
Division of Medication Error Prevention and Analysis I |
1261.571 |
Division of Risk Management |
1261.572 |
Division of Medication Error Prevention and Analysis II |
1261.573 |
Division of Mitigation Assessment and Medication Error Surveillance |
1261.574 |
Office of Pharmacovigilance and Epidemiology |
1261.58 |
Division of Epidemiology I |
1261.581 |
Division of Epidemiology II |
1261.582 |
Division of Pharmacovigilance I |
1261.583 |
Division of Pharmacovigilance II |
1261.584 |
Office of Compliance |
1262.1 |
Office of Unapproved Drugs and Labeling Compliance |
1262.3 |
Division of Compounded Drugs |
1262.31 |
Division of Unapproved New Drugs |
1262.32 |
Office of Manufacturing Quality |
1262.4 |
Division of Drug Quality I |
1262.45 |
Division of Drug Quality II |
1262.46 |
Division of Drug Quality III |
1262.47 |
Office of Scientific Investigations |
1262.5 |
Division of Good Clinical Practice Compliance |
1262.52 |
Division of Safety Compliance |
1262.53 |
Division of Enforcement and Postmarket Safety |
1262.54 |
Division of Clinical Compliance Evaluation |
1262.55 |
Office of Drug Security, Integrity and Response |
1262.6 |
Division of Global Drug Distribution and Policy |
1262.61 |
Division of Supply Chain Integrity |
1262.62 |
Office of Program and Regulatory Operations |
1262.7 |
Office of New Drugs |
1263.1 |
Office of Administrative Operations |
1263.11a |
Office of Nonprescription Drugs |
1263.12a |
Division of Nonprescription Drugs I |
1263.121 |
Division of Nonprescription Drugs II |
1263.122 |
Office of Specialty Medicine |
1263.13a |
Division of Ophthalmology |
1263.131 |
Division of Imaging & Radiation Medicine |
1263.132 |
Office of New Drug Policy |
1263.14a |
Division of Clinical Policy |
1263.141 |
Division of Regulatory Policy |
1263.142 |
Office of Regulatory Operations |
1263.15a |
Division of Regulatory Operations for Infectious Disease |
1263.151 |
Division of Regulatory Operations for Oncologic Disease |
1263.152 |
Division of Regulatory Operations for Nonprescription Drugs |
1263.153 |
Division of Regulatory Operations for Neuroscience |
1263.154 |
Division of Regulatory Operations for Cardiology, Hematology, Endocrinology & Nephrology |
1263.155 |
Division of Regulatory Operations for Immunology & Inflammation |
1263.156 |
Division of Regulatory Operations for Rare Diseases, Pediatrics, Urology & Reproductive Medicine |
1263.157 |
Division of Regulatory Operations for Specialty Medicine |
1263.158 |
Office of Program Operations |
1263.16a |
Office of Drug Evaluation Science |
1263.17a |
Division of Clinical Outcome Assessment |
1263.171 |
Division of Biomedical Informatics, Research & Biomarker Development |
1263.172 |
Office of Neuroscience |
1263.20 |
Division of Neurology I |
1263.21a |
Division of Neurology II |
1263.24a |
Division of Psychiatry |
1263.25 |
Division of Anesthesiology, Addiction Medicine & Pain Medicine |
1263.26 |
Division of Pharmacology Toxicology for Neuroscience |
1263.27 |
Office of Cardiology, Hematology, Endocrinology & Nephrology |
1263.30 |
Division of Diabetes, Lipid Disorders & Obesity |
1263.31 |
Division of General Endocrinology |
1263.32 |
Division of Cardiology & Nephrology |
1263.35 |
Division of Non-Malignant Hematology |
1263.36 |
Division of Pharmacology Toxicology for Cardiology, Hematology, Endocrinology & Nephrology |
1263.37 |
Office of Immunology & Inflammation |
1263.40 |
Division of Gastroenterology |
1263.42 |
Division of Dermatology & Dentistry |
1263.45 |
Division of Rheumatology & Transplant Medicine |
1263.46 |
Division of Pulmonology, Allergy & Critical Care |
1263.47 |
Division of Hepatology & Nutrition |
1263.48 |
Division of Pharmacology Toxicology for Immunology & Inflammation |
1263.49 |
Office of Infectious Diseases |
1263.50 |
Division of Anti-Infectives |
1263.51 |
Division of Antivirals |
1263.52 |
Division of Pharmacology Toxicology for Infectious Diseases |
1263.53a |
Office of Rare Diseases, Pediatrics, Urology & Reproductive Medicine |
1263.60 |
Division of Pharmacology Toxicology for Rare Diseases, Pediatrics, Urology & Reproductive Medicine |
1263.61a |
Division of Rare Diseases & Medical Genetics |
1263.62a |
Division of Urology, Obstetrics, & Gynecology |
1263.63a |
Division of Pediatric & Maternal Health |
1263.67 |
Office of Oncologic Diseases |
1263.70 |
Division of Oncology I |
1263.74 |
Division of Hematologic Malignancies I |
1263.75 |
Division of Oncology II |
1263.76 |
Division of Hematology Oncology Toxicology |
1263.77 |
Division of Oncology III |
1263.79 |
Division of Hematologic Malignancies II |
1263.80 |
Office of Therapeutic Biologics and Biosimilars |
1263.90 |
Office of Medical Policy |
1266.1 |
Office of Prescription Drug Promotion |
1266.11 |
Division of Advertising and Promotion Review II |
1266.111 |
Division of Advertising and Promotion Review I |
1266.112 |
Office of Medical Policy Initiatives |
1266.12 |
Division of Medical Policy Development |
1266.121 |
Division of Medical Policy Programs |
1266.122 |
Division of Clinical Trial Quality |
1266.123 |
Office of Executive Programs |
1267.1 |
Division of Learning and Organizational Development |
1267.11 |
Division of Advisory Committee and Consultant Management |
1267.13 |
Office of Translational Sciences |
1268.1 |
Office of Biostatistics |
1268.3 |
Division of Biometrics I |
1268.31 |
Division of Biometrics II |
1268.32 |
Division of Biometrics III |
1268.33 |
Division of Biometrics IV |
1268.34 |
Division of Biometrics V |
1268.35 |
Division of Biometrics VI |
1268.36 |
Division of Biometrics VII |
1268.37 |
Division of Biometrics VIII |
1268.38 |
Division of Biometrics IX |
1268.39 |
Office of Clinical Pharmacology |
1268.4 |
Division of Neuropsychiatric Pharmacology |
1268.41 |
Division of Inflammation & Immune Pharamcology |
1268.42 |
Division of Cardiometabolic & Endocrine Pharmacology |
1268.43 |
Division of Infectious Disease Pharmacology |
1268.44 |
Division of Cancer Pharmacology I |
1268.45 |
Division of Pharmacometrics |
1268.46 |
Division of Applied Regulatory Science |
1268.47 |
Division of Cancer Pharmacology II |
1268.48 |
Division of Translational & Precision Medicine |
1268.49 |
Office of Computational Science |
1268.5 |
Division of Regulatory Review & Research |
1268.51 |
Division of Tools, Technology & Innovation |
1268.52 |
Office of Study Integrity and Surveillance |
1268.6a |
Division of New Drug Study Integrity |
1268.61 |
Division of Generic Drug Study Integrity |
1268.62 |
Office of Administrative Operations |
1268.7 |
Office of Strategic Programs |
1270.2 |
Office of Program and Strategic Analysis |
1270.21 |
Office of Business Informatics |
1270.22 |
Division of Drug Quality and Compliance Services Solution |
1270.222 |
Division of Data Management Services and Solutions |
1270.223 |
Division of Business Management Services and Solutions |
1270.224 |
Division of Regulatory Review and Drug Safety Services Solutions |
1270.225 |
Office of Pharmaceutical Quality |
1280.1a |
Office of Administrative Operations |
1280.11 |
Office of Biotechnology Products |
1280.20 |
Division of Biotechnology Review and Research I |
1280.21 |
Division of Biotechnology Review and Research II |
1280.22 |
Division of Biotechnology Review and Research III |
1280.23 |
Division of Biotechnology Review and Research IV |
1280.24 |
Office of New Drug Products |
1280.30 |
Division of Life Cycle API |
1280.31 |
Division of New Drug API |
1280.32 |
Division of New Drug Products I |
1280.33 |
Division of New Drug Products II |
1280.34 |
Division of Biopharmaceutics |
1280.35 |
Division of New Drug Products III |
1280.36 |
Office of Policy for Pharmaceutical Quality |
1280.40 |
Division of Regulations, Guidance and Standards |
1280.41 |
Division of Internal Policies and Programs |
1280.42 |
Office of Pharmaceutical Manufacturing Assessment |
1280.50 |
Division of Pharmaceutical Manufacturing I |
1280.51 |
Division of Pharmaceutical Manufacturing II |
1280.52 |
Division of Pharmaceutical Manufacturing III |
1280.53 |
Division of Pharmaceutical Manufacturing IV |
1280.54a |
Division of Microbiology Assessment I |
1280.55a |
Division of Microbiology Assessment II |
1280.56 |
Division of Biotechnology Manufacturing |
1280.57 |
Office of Quality Surveillance |
1280.60 |
Division of Quality Data Science |
1280.61 |
Division of Quality Intelligence I |
1280.62 |
Division of Quality Intelligence II |
1280.63 |
Office of Testing and Research |
1280.70 |
Division of Product Quality Research |
1280.71 |
Division of Pharmaceutical Analysis |
1280.72 |
Division of Complex Drug Analysis |
1280.73 |
Office of Program and Regulatory Operations |
1280.80 |
Division of Regulatory and Business Process Management I |
1280.81 |
Division of Regulatory and Business Process Management II |
1280.82 |
Division of Regulatory & Business Process Management III |
1280.83a |
Division of Operational Excellence, Learning & Professional Development |
1280.84 |
Office of Lifecycle Drug Products |
1280.90 |
Division of Immediate & Modified Release Products I |
1280.91 |
Division of Immediate Release Products II |
1280.92 |
Division of Immediate & Modified Release Products III |
1280.93 |
Division of Liquid-Based Products I |
1280.94 |
Division of Liquid-Based Products II |
1280.95a |
Division of Post-Marketing Activities I |
1280.96a |
Division of Post-Marketing Activities II |
1280.97 |
Office of Generic Drugs |
1290.1a |
Office of Research and Standards |
1291.1a |
Division of Therapeutic Performance |
1291.11 |
Division of Quantitative Methods and Modeling |
1291.12 |
Office of Bioequivalence |
1292.1a |
Division of Bioequivalence I |
1292.11 |
Division of Bioequivalence II |
1292.12 |
Division of Bioequivalence III |
1292.13 |
Division of Clinical Review |
1292.14 |
Office of Generic Drug Policy |
1293.1a |
Division of Legal and Regulatory Support |
1293.11 |
Division of Policy Development |
1293.12 |
Office of Regulatory Operations |
1294.1a |
Division of Labeling Review |
1294.11 |
Division of Filing Review |
1294.12 |
Division of Project Management |
1294.13 |
Division of Quality Management Systems |
1294.14 |
Center for Tobacco Products |
1350.1 |
Office of the Center Director |
1351.1 |
Office of Management |
1352.1 |
Division of Financial Management |
1352.2 |
Division of Human Capital |
1352.3 |
Office of Regulations |
1354.1 |
Office of Science |
1355.1 |
Division of Regulatory Project Management |
1355.2 |
Division of Regulatory Science Informatics |
1355.3 |
Division of Product Science |
1355.4 |
Division of Individual Health Science |
1355.5 |
Division of Population Health Science |
1355.6 |
Division of Non-Clinical Science |
1355.7 |
Division of Research and Knowledge Integration |
1355.8 |
Office of Health Communication and Education |
1356.1 |
Division of Public Health Education |
1356.2 |
Division of Regulatory Communication |
1356.3 |
Division of Research and Evaluation |
1356.4 |
Office of Compliance and Enforcement |
1357.1 |
Division of Enforcement and Manufacturing |
1357.2 |
Division of Promotion, Advertising and Labeling |
1357.3 |
Division of State Programs |
1357.4 |
Division of Business Operations |
1357.5 |
Division of External Programs and Resource Management |
1357.6 |
Division of Product Compliance |
1357.7 |
Office of Regulatory Affairs |
1120.1 |
Office of the Associate Commissioner for Regulatory Affairs |
1121.1a |
Office of Regulatory Management Operations |
1121.10 |
Office of Workforce Management |
1121.14 |
Division of Human Capital Staffing Services |
1121.141 |
Division of Human Capital Programs |
1121.142 |
Office of Budget, Facilities and Travel Support |
1121.15a |
Division of Financial Operations |
1121.151a |
Division of Facilities and Property Management |
1121.152a |
Division of Contracts and Grants |
1121.153a |
Division of Travel Operations |
1121.154a |
Office of Training, Education, and Development |
1121.18 |
Division of Programmatic Training |
1121.181 |
Division of Multi-Program Leadership and Management Training |
1121.182 |
Division of Instructional Systems and Technology |
1121.183 |
Division of Testing, Measurements, and Certification |
1121.184 |
Office of Medical Products and Tobacco Operations |
1121.20a |
Office of Bioresearch Monitoring Operations |
1121.21a |
Division of Bioresearch Monitoring Operations I |
1121.211 |
Division of Bioresearch Monitoring Operations II |
1121.212 |
Office of Pharmaceutical Quality Operations |
1121.22a |
Division of Pharmaceutical Quality Program |
1121.221 |
Division of Foreign Pharmaceutical Quality Inspections |
1121.222 |
Division of Pharmaceutical Quality Operations I |
1121.223 |
Division of Pharmaceutical Quality Operations II |
1121.224 |
Division of Pharmaceutical Quality Operations III |
1121.225 |
Division of Pharmaceutical Quality Operations IV |
1121.226 |
Office of Biological Products Operations |
1121.23a |
Division of Biological Products Operations I |
1121.231 |
Division of Biological Products Operations II |
1121.232 |
Office of Medical Devices and Radiological Health Operations |
1121.24a |
Division of Medical Devices and Radiological Health Operations I |
1121.241 |
Division of Medical Devices and Radiological Health Operations II |
1121.242 |
Division of Medical Devices and Radiological Health Operations III |
1121.243 |
Office of Criminal Investigations |
1121.40 |
Office of Communications and Project Management |
1121.50 |
Division of Communications |
1121.51 |
Division of Project Management |
1121.52 |
Office of Partnerships and Operational Policy |
1121.60a |
Office of Partnerships |
1121.62 |
Division of Partnership Investments and Agreements |
1121.621 |
Division of Integration |
1121.622 |
Division of Standards Implementation |
1121.623 |
Office of Information Systems Management |
1121.70a |
Division of Enforcement Systems Solutions |
1121.71a |
Division of Import Systems Solutions |
1121.72a |
Division of Information Technology Planning and Management Services |
1121.73a |
Office of Human and Animal Food Operations |
1121.80 |
Office of State Cooperative Programs |
1121.84a |
Division of Retail Food Protection |
1121.841 |
Division of Milk Safety |
1121.842 |
Division of Shellfish Sanitation |
1121.843 |
Office of Human and Animal Food Operations East |
1121.85 |
Division of Foreign Human and Animal Food Operations East |
1121.851 |
Division of Human and Animal Food Operations East I |
1121.852 |
Division of Human and Animal Food Operations East II |
1121.853 |
Division of Human and Animal Food Operations East III |
1121.854 |
Division of Human and Animal Food Operations East IV |
1121.855 |
Division of Human and Animal Food Operations East V |
1121.856 |
Division of Human and Animal Food Operations East VI |
1121.857 |
Office of Human and Animal Food Operations West |
1121.86 |
Division of Domestic Human and Animal Food Operations West |
1121.861 |
Division of Human and Animal Food Operations West I |
1121.862 |
Division of Human and Animal Food Operations West II |
1121.863 |
Division of Human and Animal Food Operations West III |
1121.864 |
Division of Human and Animal Food Operations West IV |
1121.865 |
Division of Human and Animal Food Operations West V |
1121.866 |
Division of Human and Animal Food Operations West VI |
1121.867 |
Office of Regulatory Science |
1121.90 |
Office of Research Coordination and Evaluation |
1121.91 |
Office of Medical Products, Tobacco and Specialty Laboratory Operations |
1121.92 |
Forensic Chemistry Center |
1121.921 |
Winchester Engineering and Analytical Center |
1121.922 |
Detroit Laboratory |
1121.923 |
Northeast Medical Products Laboratory |
1121.924 |
Pacific Southwest Medical Products Laboratory |
1121.925 |
Philadelphia Laboratory |
1121.926 |
San Juan Laboratory |
1121.927 |
Southeast Tobacco Laboratory |
1121.928 |
Office of Food and Feed Laboratory Operations |
1121.93 |
Arkansas Laboratory |
1121.931 |
Denver Laboratory |
1121.932 |
Kansas City Laboratory |
1121.933 |
Northeast Food and Feed Laboratory |
1121.934 |
Pacific Northwest Laboratory |
1121.935 |
San Francisco Laboratory |
1121.936 |
Southeast Food and Feed Laboratory |
1121.937 |
Pacific Southwest Food and Feed Laboratory |
1121.938 |
Office of Import Operations |
1310.1a |
Division of Food Defense Targeting |
1310.3a |
Division of Import Operations |
1310.4a |
Division of Analysis and Program Evaluation |
1310.5a |
Division of Southwest Imports |
1310.6a |
Division of Southeast Imports |
1310.7a |
Division of Northeast Imports |
1310.8a |
Division of Northern Border Imports |
1310.9a |
Division of West Coast Imports |
1310.10a |
Division of Planning and Public Response |
1310.11a |